Kynurenine

Kynurenine

SCHEMBL4577458

Nc1ccccc1C(=O)CC(N)C(=O)O.Nc1ccccc1O

nearest known ligand 0.68

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.68
HIF1A Q16665 1/20 0.68
TDP1 Q9NUW8 1/20 0.68
ALOX15 P16050 1/20 0.46
TSHR P16473 1/20 0.46
KYNU Q16719 2/20 0.43
KIF11 P52732 1/20 0.42
GAA P10253 1/20 0.41
MAPT P10636 1/20 0.41
ALPI P09923 1/20 0.41
PKM P14618 1/20 0.41
PTGS1 P23219 1/20 0.41
XIAP P98170 1/20 0.41
SLC7A5 Q01650 1/20 0.41
KMO O15229 3/20 0.40
SLC1A3 P43003 2/20 0.40
SLC1A2 P43004 2/20 0.40
SLC1A1 P43005 2/20 0.40
GRM2 Q14416 1/20 0.40
GRM3 Q14832 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
L-Kynurenine SCHEMBL20875 0.92 KDM4E (0.64) KDM4EHIF1ATDP1KYNUGAA
Kynurenine SCHEMBL29349989 0.92 KDM4E (0.64) KDM4EHIF1ATDP1KYNUGAA
L-Kynurenine SCHEMBL13969610 0.92 KDM4E (0.64) KDM4EHIF1ATDP1KYNUGAA
L-Kynurenine SCHEMBL288989 0.92 KDM4E (0.64) KDM4EHIF1ATDP1KYNUGAA
Kynurenine SCHEMBL2181581 0.92 KDM4E (0.64) KDM4EHIF1ATDP1KYNUGAA
L-Kynurenine SCHEMBL29396313 0.92 KDM4E (0.64) KDM4EHIF1ATDP1KYNUGAA
Kynurenine SCHEMBL20874 0.92 KDM4E (0.64) KDM4EHIF1ATDP1KYNUGAA
Kynurenine SCHEMBL288988 0.92 KDM4E (0.64) KDM4EHIF1ATDP1KYNUGAA
L-Kynurenine SCHEMBL29415716 0.92 KDM4E (0.64) KDM4EHIF1ATDP1KYNUGAA
Kynurenine SCHEMBL288254 0.92 KDM4E (0.64) KDM4EHIF1ATDP1KYNUGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1311299-A4 METHOD FOR THE IDENTIFICATION OF AGENTS THAT INHIBIT OR PROMOTE CATARACTS AND USES THEREOF GEN HOSPITAL CORP (US) 2008-01-02 EP disclosed
US-7166472-B2 Method for the identification of agents that inhibit or promote cataracts and uses thereof THE GENERAL HOSPITAL CORPORATION (US) 2007-01-23 US disclosed
US-20050084918-A1 Method for the identification of agents that inhibit or promote cataracts and uses thereof BUSH ASHLEY I (US) 2005-04-21 US disclosed
EP-1311299-A1 METHOD FOR THE IDENTIFICATION OF AGENTS THAT INHIBIT OR PROMOTE CATARACTS AND USES THEREOF THE GENERAL HOSPITAL CORPORATION (US) 2003-05-21 EP disclosed
WO-2002015942-A1 METHOD FOR THE IDENTIFICATION OF AGENTS THAT INHIBIT OR PROMOTE CATARACTS AND USES THEREOF THE GENERAL HOSPITAL CORPORATION (US) 2002-02-28 WO disclosed